Carbognin, Luisa
 Distribuzione geografica
Continente #
NA - Nord America 2.317
EU - Europa 2.059
AS - Asia 1.394
SA - Sud America 175
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 42
OC - Oceania 4
Totale 6.061
Nazione #
US - Stati Uniti d'America 2.258
RU - Federazione Russa 855
CN - Cina 457
SG - Singapore 450
GB - Regno Unito 393
IT - Italia 208
VN - Vietnam 141
SE - Svezia 130
BR - Brasile 128
DE - Germania 127
HK - Hong Kong 107
IE - Irlanda 98
FR - Francia 95
KR - Corea 58
FI - Finlandia 48
IN - India 41
BD - Bangladesh 39
NL - Olanda 29
CA - Canada 23
JP - Giappone 23
UA - Ucraina 19
AR - Argentina 13
TR - Turchia 12
MX - Messico 10
PL - Polonia 10
EC - Ecuador 9
PK - Pakistan 9
ZA - Sudafrica 9
ES - Italia 8
ID - Indonesia 8
JM - Giamaica 8
NG - Nigeria 8
VE - Venezuela 8
UZ - Uzbekistan 7
MA - Marocco 6
CO - Colombia 5
IQ - Iraq 5
SA - Arabia Saudita 5
AL - Albania 4
AT - Austria 4
CH - Svizzera 4
GR - Grecia 4
NI - Nicaragua 4
PT - Portogallo 4
AU - Australia 3
BJ - Benin 3
BO - Bolivia 3
CY - Cipro 3
DZ - Algeria 3
EG - Egitto 3
IR - Iran 3
KZ - Kazakistan 3
LT - Lituania 3
MY - Malesia 3
PY - Paraguay 3
RO - Romania 3
TG - Togo 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BE - Belgio 2
CL - Cile 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
KE - Kenya 2
KG - Kirghizistan 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GF - Guiana Francese 1
HT - Haiti 1
IL - Israele 1
JO - Giordania 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 5.988
Città #
Southend 328
Moscow 307
Ashburn 288
Chandler 263
San Jose 248
Singapore 209
Woodbridge 133
Dallas 131
Hong Kong 104
Beijing 102
Dublin 96
New York 83
Verona 69
Council Bluffs 68
The Dalles 64
Ho Chi Minh City 61
Jacksonville 57
Los Angeles 49
Munich 45
Ann Arbor 44
Lawrence 31
Princeton 31
Hanoi 30
Wilmington 29
Santa Clara 28
Jinan 25
Shenyang 25
Nanjing 23
Tianjin 23
Seoul 22
Orem 20
London 19
Chennai 18
Tokyo 18
Turku 18
Buffalo 17
Columbus 15
Redondo Beach 15
Guangzhou 14
Houston 14
Denver 13
Frankfurt am Main 13
Hebei 13
São Paulo 12
Zhengzhou 12
Atlanta 11
Sindelfingen 11
Brooklyn 10
Changsha 10
Seattle 9
Vicenza 9
Abuja 8
Manchester 8
Mexico City 8
Mumbai 8
Ningbo 8
Amsterdam 7
Barnet 7
Milan 7
Rome 7
San Francisco 7
Stockholm 7
Tashkent 7
Boston 6
Charlotte 6
Chicago 6
Florence 6
Haikou 6
Hangzhou 6
Helsinki 6
Johannesburg 6
Kingston 6
Lancaster 6
Montreal 6
Nanchang 6
Paris 6
Phoenix 6
Rio de Janeiro 6
Taiyuan 6
Biên Hòa 5
Las Vegas 5
Markgröningen 5
Redmond 5
Redwood City 5
Shanghai 5
Warsaw 5
Acalanes Ridge 4
Augusta 4
Bologna 4
Cagliari 4
Campo Grande 4
Dearborn 4
Haiphong 4
Hải Dương 4
Marseille 4
Meda 4
New Delhi 4
Newark 4
Poplar 4
Queens 4
Totale 3.583
Nome #
Identification of clinical, pathological and molecular predictors of prognosis in early-stage invasive lobular breast cancer: role of proliferation and CDK4/6 pathway. 233
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 232
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer 225
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 216
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials 213
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 208
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 206
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 206
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 199
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 199
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 186
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 183
Tubulin inhibitors in non-small cell lung cancer: looking back and forward 180
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer 177
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research 174
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival 171
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting 170
MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy 167
Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome 163
Muscle derangement and alteration of the nutritional machinery in NSCLC 160
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 157
Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system. 156
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 152
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 150
Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment 149
Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over? 146
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis 141
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer 141
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 138
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 138
Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity 137
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success 136
Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option? 135
The obesity paradox in cancer: clinical insights and perspectives 125
Tracking MET de-addiction in lung cancer: A road towards the oncogenic target. 111
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 67
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer 14
Totale 6.061
Categoria #
all - tutte 21.022
article - articoli 19.836
book - libri 0
conference - conferenze 632
curatela - curatele 0
other - altro 554
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022157 0 0 0 33 11 3 3 8 13 6 15 65
2022/2023645 36 90 39 134 57 151 3 37 64 1 20 13
2023/2024355 14 24 16 27 54 75 7 32 10 34 55 7
2024/2025812 38 33 44 158 26 38 16 20 138 56 86 159
2025/20262.613 178 103 150 452 743 142 188 129 233 175 59 61
2026/2027335 21 57 102 155 0 0 0 0 0 0 0 0
Totale 6.061